As anyone with pelvic pain or pudendal neuralgia will tell you, it is amongst THE most painful conditions known to man and there are really no effective treatments for it.  Seeing an opportunity to make more money through the desperation of these patients, hordes of physicians with no training in pain management whatsoever, let alone pelvic pain, advertise themselves as “Pelvic Experts” in an effort to convince these patients to make appointments.  In the end, these patients are left to suffer in pain even longer, utilizing pointless treatments with no evidence for months on end and administered by those with no qualifications in this sub-specialty.  Treatments like “hydrodissection” or charging cash to administer regenerative medicines that were designed for joint injuries into the pelvic region are shams that only serve to make the clinicians money.  The HOPE Trial aspires to change all of that…once and for all.

While droves of physicians have all shared in the success of using the DRG Stimulator for pelvic pain based on Dr. Hunter’s research (which was published in 2018), the Ainsworth Institute “hopes” to prove unequivocally, in a neutral and unbiased format, that this technique should become the standard-of-care for these patients. 

This clinical trial is a prospective study examining the efficacy of DRG Stimulation for pelvic pain and pudendal neuralgia.  As DRG stimulation is already commercially available, the cost of the treatment is funded through one’s insurance – this means that anyone participating in the study would be required to have medical insurance.  As such, consultation and treatment associated visits would be subject to insurance policy of the individual which includes deductibles, co-insurances and copays.

Study Enrollment Form
Official Protocol Name: HOPE Trial – Dorsal Root Ganglion (DRG) Stimulation for the Treatment of Chronic Pelvic Pain